Introduction {#sec1-1}
============

In ancient medicine, Shushrutha described a condition, "vidari" under mouth and throat diseases. He noted progressive narrowing of mouth, depigmentation of oral mucosa, and pain on taking food. These features precisely fit in with the symptomatology of oral submucous fibrosis.\[[@ref1]\] Schwartz (1952) for the first time reported a case of "atrophica idiopathica tropica mucosae oris" occurring in Indians in East Africa. Lal and Joshi (1953) first described this condition in India. Joshi coined the term "oral submucous fibrosis (OSMF)."\[[@ref2]\] Pindborg and Sirsat (1966) described histologically, the four consecutive stages of the OSMF.\[[@ref3]\] Seedat and Van Wyk (1988) have reported about irreversible nature of the disease, that is, once OSMF induced by the habit of chewing betel nut, the reversal of the disease after cessation of the habit could not occur.\[[@ref4]\]

The magnitude of the situation can be gauged by facts stated in a 2004 review that India ranks the highest among all the registries in the world for incidence of oral cancer with 75,000\--80,000 cases reported each year. For many years, this condition had been confined to countries like India, Pakistan, Bangladesh, etc., but now due to higher rates of immigration this condition is being reported from Western countries as well.\[[@ref5][@ref6][@ref7]\]

This epidemic in part is due to the sudden spurt in the number of industries involved in the convenient and inexpensive packaging and vigorous advertising of products like gutkha and pan masala which was commercially started in 1980 in India. Major steps in curbing this serious health issue by the Government are missing mainly due to the fear of affecting the livelihood of farmers and others involved in this industry. Karnataka, a state of India grows about 65% of the total areca nut produced in the country, yet a ban was just recently imposed on gutkha after several other states banned the product under the Food safety and standards act. Farmers need to be educated regarding the ill effects and encouraged to grow other crops which can bring them profits.\[[@ref5][@ref8][@ref9][@ref10][@ref11]\]

The World Health Organization predicts that tobacco deaths in India may exceed 1.5 million annually by 2020. Oral cancer progress through the transformation of tobacco exposed normal oral mucosa to potentially malignant lesions which ultimately changes to carcinoma. OSMF is now globally accepted as an Indian disease. It has one of the highest rates of malignant transformation among potentially malignant oral lesions.\[[@ref12][@ref13]\]

Primary healthcare physician can play a very vital role in early diagnosis of OSMF considering its progressive nature. It is a restrictive condition of oral cavity with multifactorial etiology with areca nut chewing most common one. Prevalence of this deleterious habit in India is on rise so this disease which once used to be rare has become very common, hence the awareness of the clinical features, diagnosis, and management is the main stay to curb this menace. Hence, role of primary healthcare physician, being the first point of contact for general population, becomes paramount. The present study was conducted to evaluate the prevalence of OSMF among betel nut chewers in different age groups among north Indian population.

Materials and Methods {#sec1-2}
=====================

A cross-sectional study was conducted in Outpatient Department of the Oral Medicine and Radiology for 24 months. Approval from the Ethical Committee of the Institute was obtained and informed consent was taken from the participants. OSMF patients were divided according to gender. A total of 860 OSMF patients were screened out. All oral examinations were done by specialist examiners who were familiar with oral mucosal lesions in the local population. A sterile mouth mirror was used for retraction of tissues, and examination of oral cavity was done using examination gloves. The selected patients were divided into four groups according to their clinical stage:

**Stage I:** Interincisal mouth opening up to or greater than 35 mm, stomatitis, and blanching of oral mucosa.

**Stage II:** Interincisal mouth opening between 25 and 35 mm, presence of palpable fibrous band in buccal mucosa and/or oroparynx, with/without stomatitis.

**Stage III:** Interincisal mouth opening between 15 and 25 mm; presence of palpable fibrous bands in buccal mucosa and/or or pharynx, and in any other parts of the oral cavity.

**Stage IV:** Interincisal mouth opening less than 15 mm.

**A.** Any other stage along with other potentially malignant disorders, for example, oral leukoplakia, oral erythroplakia, etc.

**B.** Any other stage along with oral carcinoma.

The OSMF patients were divided in four categories on the basis of age groups:

Group I: 10--20 yearsGroup II: 20--30 yearsGroup III: 30--40 yearsGroup IV: 40--50 years.

Prevalence of OSMF was also recorded on the basis of habit duration and divided in three groups:

Group A: 2--5 yearsGroup B: 5--10 yearsGroup C: More than 10 years.

This study was conducted on the basis of the type of habit and divided into three groups:

Group 1: Guthka, pan masala.Group 2: Betal quid.Group 3: Tobacco, smoking.

Patients suffering from any systemic diseases and children below the age of 10 years were excluded from this study. Data was analyzed using IBM SPSS Statistics version 21 (IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.). Descriptive statistics included calculation of means and standard deviation. Data distribution was assessed for normality using Shapiro\--Wilk test. Chi-square test was used for comparing the categorical data. All values were considered statistically significant for a value of *P* \< 0.05.

Results {#sec1-3}
=======

There were 31,570 subjects in total being screened up, 860 subjects were found to be suffering from OSMF. [Figure 1](#F1){ref-type="fig"} shows out of 860 subjects, 840 were males (97.33%) and 20 were females (2.33%). According to mouth opening, OSMF was divided in four stages. [Table 1](#T1){ref-type="table"} shows more prevalence in stage II 402 (46.74%), followed by stage III 298 (34.66%), stage I 90 (10.47%), and stage IV 70 (8.14%). [Table 2](#T2){ref-type="table"} shows the prevalence on the basis of age groups, more prevalence of OSMF was found in group III (34.42%), followed by group II (30.70%), group IV (27.91%), group I (4.65%), and group V (2.33%). In Group I, more prevalence was found in stage II (75%) OSMF than stage I (25%). In Group II, approximately equal prevalence was found in stage II (34.09%) and stage III (35.61%). Less prevalence was recorded in stage I (30.30%) under group II. In Group III, more prevalence was found in stage II (54.73%) OSMF than stage III (45.27%) OSMF. No prevalence was found in stage I and stage IV. In Group IV, more prevalence was found in stage II (50%) OSMF followed by than stage III (29.17%) and stage IV (20.83%) OSMF. Finally, in group V, all 20 patients were found in stage IV. (*P* \< 0.001).

![Gender wise distribution of OSMF](JFMPC-8-2612-g001){#F1}

###### 

Prevalence of OSMF on the basis of clinical staging

  OSMF stage   Number   Percentage   Mean   Standard deviation
  ------------ -------- ------------ ------ --------------------
  Stage I      90       10.47%       215    161.77
  Stage II     402      46.74%              
  Stage III    298      34.66%              
  Stage IV     70       8.14%               
  Total        860                          

###### 

Prevalence of OSMF on the basis of age group

  Age group (in years)      Total   Percentage   Stage     Number   Percentage   Mean±SD
  ------------------------- ------- ------------ --------- -------- ------------ ----------
  10-20 years (Group I)     40      4.65%        Stage I   10       25%          10±0.142
  Stage II                  30      75%                                          
  Stage III                 00      \-                                           
  Stage IV                  00      \-                                           
  20-30 years (Group II)    264     30.70%       Stage I   80       30.30%       66±7.79
  Stage II                  90      34.09%                                       
  Stage III                 94      35.61%                                       
  Stage IV                  00      \-                                           
  30-40 years (Group III)   296     34.42%       Stage I   00                    74±11.25
  Stage II                  162     54.73%                                       
  Stage III                 134     45.27%                                       
  Stage IV                  00      \-                                           
  40-50 years (Group IV)    240     27.91%       Stage I   00       \-           60±5.23
  Stage II                  120     50%                                          
  Stage III                 70      29.17%                                       
  Stage IV                  50      20.83%                                       
  50-60 years (Group V)     20      2.32%        Stage I   00       \-           5±0.11
  Stage II                  00      \-                                           
  Stage III                 00      \-                                           
  Stage IV                  20      100%                                         
  *P*\<0.05                 860                                                  

[Table 3](#T3){ref-type="table"} shows the prevalence of OSMF on the basis of duration of habit. Group A consisted of people with a habit duration of 2--5 years. Group B consisted of people with a habit duration of 5--10 years, and Group C consisted of people with habit duration of more than 10 years. High prevalence was found in Group C (48.84%) in comparison to Group B (47.67%) and Group A (3.49%). This prevalence was statically significant (*P* \< 0.001).

###### 

Prevalence of OSMF on the basis of duration of habits

  Duration of habit              Total   Percentage   Stage     Number   Percentage   Mean±SD
  ------------------------------ ------- ------------ --------- -------- ------------ -------------
  2-5 years (Group A)            30      3.49%        Stage I   30       100%         7.5±0.12
  Stage II                       00      \-                                           
  Stage III                      00      \-                                           
  Stage IV                       00      \-                                           
  5-10 years (Group B)           410     47.67%       Stage I   60       14.63%       102.5±13.56
  Stage II                       156     38.05%                                       
  Stage III                      174     42.44%                                       
  Stage IV                       20      4.88%                                        
  More than 10 years (Group C)   420     48.84%       Stage I   0        \-           105±15.02
  Stage II                       246     58.57%                                       
  Stage III                      124     29.52%                                       
  Stage IV                       50      11.90%                                       
  *P*\<0.05                      860                                                  

[Table 4](#T4){ref-type="table"} shows the frequency of the habit (per day), it was divided in three groups. Group A had a habit frequency of 2--5 times/day; Group B had a habit frequency of 5--10 times/day, and Group C had a habit frequency of more than 10 times/day. Prevalence was more in Group C (45.81%) in comparison to Group B (41.86%) and Group A (12.33%). The prevalence was statistically significant (*P* \< 0.001).

###### 

Prevalence of OSMF on the basis of frequency of habit per day

  Frequency habit/day                Total   Percentage   Stage     Number   Percentage   Mean±SD
  ---------------------------------- ------- ------------ --------- -------- ------------ ------------
  2-5 times/day (Group A)            106     12.33%       Stage I   60       56.60%       26.5±3.82
  Stage II                           46      43.40%                                       
  Stage III                          00      \-                                           
  Stage IV                           00      \-                                           
  5-10 times/day (Group B)           360     41.86%       Stage I   30       8.33%        90±20.04
  Stage II                           210     58.33%                                       
  Stage III                          105     29.17%                                       
  Stage IV                           15      4.17%                                        
  More than 10 times/day (Group C)   394     45.81%       Stage I   0        \-           98.5±21.11
  Stage II                           146     37.05%                                       
  Stage III                          193     48.98%                                       
  Stage IV                           55      13.96%                                       
  *P*\<0.05                          860                                                  

[Figure 2](#F2){ref-type="fig"} shows prevalence of OSMF on the basis of type of habits. Out of 860 habituated subjects, 480 (55.81%) were in the habit of taking gutkha, 60 (6.98%) were in the habit of taking betal quid and gutkha, 230 (26.74%) were in the habit of taking tobacco and gutkha, 90 (10.46%) were in the habit of smoking and gutkha.
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Discussion {#sec1-4}
==========

Yang assessed the prevalence, gender distribution, age, income, and urbanization status of OSF patients in Taiwan. Patients were diagnosed with OSMF during the period between January 1, 1996 and December 31, 2013. It showed that the prevalence of OSMF increased significantly from 8.3 (per 10 (5)) in 1996 to 16.2 (per 10 (5)) in 2013 (*P* \< 0.0001). Men had a significantly higher OSMF prevalence than women.\[[@ref14]\] Sinor *et al.* in India found male predominance in OSMF cases.\[[@ref15]\] In present study, male predominance can be due to easy accessibility for males to use areca nut and its products more frequently than females. Male patients were more in comparison to females, with a prevalence of OSMF 97.67% compared with 2.33% in females.

Mehrotra conducted a study to evaluate the prevalence rates of oral mucosal lesions in this hospital from 1990 to 2001 in Allahabad, North India. Data was collected year wise with reference to age, sex, site involved, and histopathological findings. It showed that potentially malignant and malignant oral lesions were widespread in the patients visiting the hospital in this region.\[[@ref16]\] Similarly, in a population-based case control study in rural and urban Lucknow, it was found that patients who use pan masala were at higher risk of developing OSMF.\[[@ref17]\]

The findings of Babu *et al.*, among OSF patients in Hyderabad, showed that people were more addicted to gutkha than any other related areca nut and tobacco products such as pan, pan masala, and raw areca nut. They found a strong association between gutkha chewing and OSMF and pointed that gutkha consumption led to OSMF.\[[@ref18]\] Nigam *et al.* determined the prevalence and severity of OSMF among habitual gutkha, areca nut, and pan chewers of Moradabad, India. The prevalence of OSF was 6.3% and gutkha chewing was the most common abusive habit among OSF patients in the study.\[[@ref19]\] Similarly, in the present study, habitual gutkha chewing was more prevalent than gutkha with tobacco.

In this study, the 860 patients were in the age range of 15--60 years, with a peak incidence in 30\--40 years (34.88%), followed by 20--30 years (30.23%). Hence, it can be concluded that the occurrence of OSMF is seen most commonly in age group 30\--40 years followed by 20--30 years. The youngest patient was 16-year-old, and the eldest was 60-year-old. The observation of present study was similar to study conducted by Nigam, who reported the maximum number of OSMF cases were in the age group of 36\--40 years.\[[@ref19]\] This could be because of increased social encounters and economic liberty they get at this age in a rapidly developing nation like India. Therefore, during this age, they indulge in various chewing habits such as betel nut, guthka, pan masala, smoking, alcohol, etc., either to relieve stress, as a fashion or due to peer pressure.

Shah found the relationship between OSMF to various chewing and smoking habits. It was found that chewing of areca nut/quid or pan masala (a commercial preparation of areca nuts, lime, catechu and undisclosed coloring, flavoring, and sweetening agents) was directly related to OSMF and frequency of chewing rather than the total duration of the habit was directly correlated to OSMF.\[[@ref20]\] Ali *et al.* evaluated the effect of frequency, duration, and type of areca nut products on the incidence and severity of OSMF. It showed that the duration and frequency of its use and type of areca nut product has effect on the incidence and severity of OSMF. Gutkha and pan masala have more deleterious and faster effects on oral mucosa. The gutkha-chewing habit along with the other habits does not have any significant effect on the rate of occurrence and incidence and severity of the OSMF.\[[@ref21]\] Present study showed significant effect of duration and frequency of use of areca nut products on the incidence and severity of OSMF.

In present study, clinical staging of all 860 OSMF patients was assessed. It was found that maximum patients were seen in stage II (46.42%) and stage III (34.52%), followed by stage I (10.73%) and stage IV (8.33%). Kumar found in his study of 1,006 OSMF patients, 422 (41.94%) cases were stage II. Two hundred and twenty six (22.29%) were stage IV, 184 (18.29%) stage III, and 174 (17.29%) stage I which is somewhat different to present study.\[[@ref22]\] This could be on the grounds that in the early cases significant changes particularly, limited mouth opening are not seen, and unless there is a significant affection of the functions patient\'s body, patients won't approach the doctor, and furthermore an absence of information about the illness can likewise ascribe to this.

The conversion of premalignant to malignant condition varies from 3% to 19%. A recent study from India has reported that 25.77% OSF cases converted to oral squamous cell carcinoma (OSCC) which indicates the alarming malignant potential of OSMF.\[[@ref23]\]

Epidemiological data accumulated over a wide geographical area will help to determine the overall incidence and prevalence rates and formulate appropriate prevention and control measures. High risk individual and population for tobacco usages needs to be targeted and intervention should be done at community level. Policies need to be laid down by concerned policy makers to curb this ever progressing menace. Primary healthcare professionals and dentists should play an active role in prevention and control of tobacco induced lesions as they are generally the first point of contact with patients who are at increased risk.

Conclusion {#sec1-5}
==========

The easy availability and promotions of these areca nut products especially gutkha and pan masala in social places has impacted general population in India which has led to the increased occurrence of OSMF, a premalignant condition. In present study, the occurrence of OSMF in gutkha chewers is far faster and more severe as compared with other forms of areca nut products chewers. Frequency of the habit showed statistical significance indicating that as frequency of habit increases, severity of the disease also increased. The high prevalence of OSMF requires significant awareness and management of these lesions among general population. Primary healthcare professionals including dentists should be knowledgeable and familiar with the etiopathogenesis, clinical presentation, diagnosis, and management of these lesions.
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